Monday , May 20 2019
Home / Financial News / Interview with Dr Raza Bokhari about FSD Pharma

Interview with Dr Raza Bokhari about FSD Pharma

Dr Raza Bokhari, Executive Co-Chairman & Interim CEO CSE:HUGE, OTC:FSDDF, FRA:0K9

FSD has 25,000 square feet available for production at its Ontario facility with an additional 220,000 square feet currently in development.

FSD’s R&D platform is focused on cannabinoids and their potential for widespread clinical applications. FSD has a strong interest in acquiring an R&D platform with the capability of producing synthetic cannabinoids and intends to create FDA approved medications that will be commercialized internationally.

SOURCE: FSD Pharma

About Investment Value Finders

Check Also

World Class Extractions to service pot growers

World Class Extractions to service pot growers

As the legal cannabis consumption trend continues to gain steam, most of the sector participants …